Application of white-bone earth fruit extract in promoting osteoblast differentiation and improving osteoporosis
An osteoblast differentiation promoter prepared by extracting Avicennia marina fruit solves the problem of limited efficacy of existing osteoporosis treatment drugs, enhances osteoblast differentiation and mineralization functions, and has good potential for industrial application.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- GUANGDONG MEDICAL UNIV
- Filing Date
- 2026-04-22
- Publication Date
- 2026-06-19
AI Technical Summary
Existing osteoporosis treatments have limited effects on improving osteogenic function and have adverse reactions, making it difficult to meet clinical needs. There is a need for a natural, safe, and effective osteoblast differentiation promoter.
An osteoblast differentiation promoter was prepared by using extracts of Avicennia marina fruit, which were extracted with n-butanol and then combined with ethyl acetate and n-butanol extraction, to promote the differentiation and mineralization functions of osteoblasts.
The extract of *Avicennia marina* fruit significantly promotes osteoblast differentiation and mineralization, exhibiting a good dose-dependent effect, and has potential application prospects for treating osteoporosis and promoting fracture repair.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3